Skip to main content

Nephrology in Mexico

  • Chapter
  • First Online:
Nephrology Worldwide

Abstract

Nephrology in Mexico started in 1955 with the opening of the nephrology department at Mexico’s National Heart Institute, where the first nephrology training program began in 1958. Pediatric nephrology care was first offered at Mexico’s Federico Gomez Children’s Hospital in 1953, among the first pediatric nephrology programs in the world. Kidney transplantation began in 1963 at the IMSS General Hospital. The Sociedad Mexicana de Nefrologia, the first Mexican nephrology society, was established in 1967, followed by the publication of Nefrologia Mexicana, its official journal, in 1980.

Chronic kidney disease has emerged as a public health problem in Mexico. However, the fragmentation of the health system has resulted in unequal access to renal replacement therapy. Seguro Popular, a public health-care insurance for the poor, does not cover renal replacement therapy. As a consequence, many uninsured patients refuse dialysis, eventually abandon their treatment, or lose their kidney grafts because sustaining dialysis or immunosuppression becomes unaffordable. The lack of a national dialysis registry results in a vacuum of information on the burden of treated end-stage renal disease and its outcomes. In addition to the high burden of traditional risk factors (i.e., diabetes mellitus), a number of “hotspots” of chronic kidney disease of unknown origin have been recently described in the country. Despite the increased burden of chronic kidney disease, strategies to prevent chronic kidney disease have not been part of the nation’s noncommunicable disease health policies. Chronic kidney disease screening is not part of the National Health Surveys. Peritoneal dialysis continues to be the dialysis modality of choice, although a significant shift to hemodialysis has been observed over the last two decades. The number of nephrologists (9.1 per million population) is insufficient to match the demand imposed by the burden of chronic kidney disease. In conclusion, after 65 years of the beginning of nephrology in Mexico, kidney disease care remains unjust, unequal, and below the quality of international standards. The current infrastructure and resources are insufficient to satisfy the demand of renal care in our society. Therefore, it is important to consider it as a public health priority and to implement a comprehensive program for the prevention and control of this illness. The establishment of a national public policy for the prevention and treatment of chronic kidney disease is urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Referencias geográficas y extension territorial de Mexico. Aguascalientes: Instituto Nacional de Geografía y Estadística (INEGI); 2018. Available from: https://www.inegi.org.mx/inegi/spc/doc/internet/1-geografiademexico/man_refgeog_extterr_vs_enero_30_2088.pdf.

  2. Proyecciones de la población y conciliación demográfica. Mexico City: Consejo Nacional de Población (CONAPO); 2019. Available from: https://www.gob.mx/conapo.

  3. The World Bank. Mexico data. The World Bank; 2018. Available from: https://data.worldbank.org/country/mexico.

  4. Human Development Indicators. Mexico: United Nations Development Programme; 2019. Available from: http://hdr.undp.org/en/countries/profiles/MEX.

  5. Nefrologos con certificación vigente. Mexico City: Consejo Mexicano de Nefrología, A.C.; 2019. Available from: http://consejomexicanodenefrologia.org/nefrologos-con-certificacion-vigente/.

  6. United States Renal Data System. 2018 USRDS annual data report: epidemiology of kidney disease in the United States Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018. Available from: https://www.usrds.org/2018/view/Default.aspx.

  7. Boletín Estadístico Informativo del Centro Nacional de Trasplantes: Centro Nacional de Trasplantes (CENATRA); 2018. Available from: https://www.gob.mx/cms/uploads/attachment/file/484466/BEI-CENATRA_Vol._III__No._2_ENE-DIC_2018_WEB.pdf.

  8. Mexico. Facts, history and news: info please; 2012. Available from: https://www.infoplease.com/world/countries/mexico.

  9. Catalogo de las lenguas indígenas nacionales: Variantes lingüisticas de México con sus autodenominaciones y referencias geostadísticas. Mexico City: Instituto Nacional de Lenguas Indígenas (INALI); 2008. Available from: https://www.inali.gob.mx/clin-inali/.

  10. Mexico Economic Snapshot: Organization for Economic Co-operation and Development (OECD); 2019. Available from: http://www.oecd.org/economy/mexico-economic-snapshot/.

  11. Frenk J, González-Pier E, Gómez-Dantés O, Lezana MA, Knaul FM. Comprehensive reform to improve health system performance in Mexico. Lancet. 2006;368(9546):1524–34.

    Article  PubMed  Google Scholar 

  12. Garcia-Garcia G, Chavez-Iñiguez JS. The tragedy of having ESRD in Mexico. Kidney Int Rep. 2018;3(5):1027–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Frenk J, Knaul FM, Gomez-Dantes O, Arreola-Ornelas H. La brecha de la salud. Mexico City: Nexos; 2018. Available from: https://www.nexos.com.mx/?p=35971.

  14. Instituto De Salud para el Bienestar. Mexico City: Secretaria de Salud; 2020. Available from: https://www.gob.mx/insabi.

  15. Torres-Zamora M. History of the Mexican Society of Nephrology, currently Colegio de Nefrologos de Mexico. Nefrologia Mexicana. 2011;32(4):107–8.

    Google Scholar 

  16. Mota-Hernandez F, Velazquez-Jone L. Homenaje a Dr. Gustavo Gordillo Paniagua (1923–2012). Arch Latin Nefr Ped. 2013;13:3–28.

    Google Scholar 

  17. Garcia-Aranda JA, Madeiros M. Hospital Infantil de Mexico Federico Gomez. historical brief. Rev Investig Clin. 2009;61(5):351–3.

    Google Scholar 

  18. Santos-Atherton D. Antecedentes. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrología en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 23–6.

    Google Scholar 

  19. Teran-Ortiz LA, Diaz-Muñoz I, Alvarez-Balbas L, Silvia O-E. Los trasplantes de organos y tejidos en Mexico. Medicina Universitaria. 2001;3(12):191–4.

    Google Scholar 

  20. Garcia-Alvarez R, Fernandez de Castro J. Remembranzas de un pediatra: origen y breve historia de la nefrologia pediatrica en Mexico. Rev Med Pediatr. 2013;80(5):211–2.

    Google Scholar 

  21. Treviño-Becerra A. Consejo Mexicano de Nefrología. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrologia en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 281–8.

    Google Scholar 

  22. Trinidad-Ramos P. Transición de la Sociedad Mexicana de Nefrologia, A.C., a Colegio de Nefrologos de Mexico, A.C. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrologia en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 257–64.

    Google Scholar 

  23. Abraham-Bermudez J. Instituto Mexicano de Investigaciones Nefrologicas. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrologia en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 265–72.

    Google Scholar 

  24. Garcia-Garcia G. Asociacion Nacional de Nefrologos de Mexico. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrologia en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 273–4.

    Google Scholar 

  25. Torres-Zamora MI. Revista Nefrologia Mexicana. In: Treviño-Becerra A, editor. Relatos: 50 años de la nefrologia en Mexico: de Sociedad a Colegio. Mexico City: Editorial Prado; 2017. p. 241–4.

    Google Scholar 

  26. Robinson RR, Richet G. International society of nephrology: a forty year history. 1960–2000. Kidney Int Suppl. 2001;79:S1–100.

    Article  CAS  PubMed  Google Scholar 

  27. Nolph KD. 1975 to 1984—an important decade for peritoneal dialysis: memories with personal anecdotes. Perit Dial Int. 2002;22(5):608–13.

    Article  PubMed  Google Scholar 

  28. OECD Reviews of Health Systems. Mexico 2016. 2016. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/oecd-reviews-of-health-systems-mexico-2016_9789264230491-en.

  29. Aldrete-Velasco J, Chiquete E, Rodriguez-Garcia J, Rincon-Pedrero R, Correa-Rotter R, Garcia-Peña R, et al. Chronic kidney disease mortality and its relation to diabetes in Mexico. Med Int Mex. 2018;34(4):536–50.

    Google Scholar 

  30. Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2016;388(10058):2386–402.

    Article  PubMed  Google Scholar 

  31. Amato D, Alvarez-Aguilar C, Castañeda-Limones R, Rodriguez E, Avila-Diaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005;97:S11–7.

    Article  Google Scholar 

  32. Gutierrez-Padilla JA, Mendoza-Garcia M, Plascencia-Perez S, Renoirte-Lopez K, Garcia-Garcia G, Lloyd A, et al. Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico. Am J Kidney Dis. 2010;55(3):474–84.

    Article  CAS  PubMed  Google Scholar 

  33. Garcia-Garcia G, Gutierrez-Padilla AJ, Chavez-Iniguez J, Perez-Gomez HR, Mendoza-Garcia M, Gonzalez-De la Pena MD, et al. Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations. Arch Med Res. 2013;44(8):623–7.

    Article  CAS  PubMed  Google Scholar 

  34. Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, Olvera N, Ferreira E, et al. Prevalence of chronic kidney disease in the kidney early evaluation program (KEEP) Mexico and comparison with KEEP US. Kidney Int. 2010;77:S2–8.

    Article  Google Scholar 

  35. Chávez-Iñiguez JS, García-García G, Lombardi R. Epidemiología y desenlaces de la lesión renal aguda en Latinoamérica. Gac Med Mex. 2018;154(Suppl 1):S6–S14.

    PubMed  Google Scholar 

  36. Córdova-Sánchez BM, Herrera-Gómez Á, Ñamendys-Silva SA. Acute kidney injury classified by serum creatinine and urine output in critically ill cancer patients. Biomed Res Int. 2016;2016:6805169.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Vázquez-Rodríguez JG, Solís-Castillo LA, Cruz-Martínez FJ. Frequency and clinical evolution of acute renal failure in obstetric patients treated in the intensive care unit of a high-specialty hospital in Mexico City. Med Intensiva. 2017;41(4):255–7.

    Article  PubMed  Google Scholar 

  38. Valdez-Diaz R, Wong-Estrello R, Flores-Ydrack E, Basoni-Ruiz AE, Esquivel-Molina CG, Gonzalez-Ortiz LA, et al. Nefropatia por medio de contraste en angiografia cardiaca. Med Int Mex. 2010;26(3):226–36.

    Google Scholar 

  39. Santibáñez-Velázquez M, Sánchez-Montoya F, Alvirde-Gutiérrez L. Survival in acute renal failure with conventional therapy or continuous replacement therapy. Rev Med Inst Mex Seguro Soc. 2014;52(3):254–7.

    PubMed  Google Scholar 

  40. Alba L, Espinosa R, Castro L, Reyes E. Incidence of nephrotoxicity in patients infected, treated with colistimethate. Enf Inf Microbiol. 2013;33(3):109–12.

    Google Scholar 

  41. Cruz-Martinez E, Hernandez-Rojas ME, Molinar-Ramos F. Funcion renal del paciente critico con falla renal aguda en relacion a niveles de depuracion de creatinina. Rev Asoc Mex Med Crit. 1999;13(5):155–9.

    Google Scholar 

  42. Higuera-de la Tijera MF, Pérez-Hernández JL, Servín-Caamaño AL, Serralde-Zúñiga AE, Cruz-Palacios A. The amount of alcohol intake, upper gastrointestinal bleeding, acute renal failure and hepatic encephalopathy as the risk factors implied in the increase of patients with alcoholic hepatitis. Rev Gastroenterol Mex. 2009;74(4):306–13.

    CAS  PubMed  Google Scholar 

  43. Moguel-González B, Wasung-de-Lay M, Tella-Vega P, Riquelme-Mc-Loughlin C, Villa AR, Madero M, et al. Acute kidney injury in cardiac surgery. Rev Investig Clin. 2013;65(6):467–75.

    Google Scholar 

  44. Chavez-Iñiguez JS, Garcia-Garcia G, Briseño-Ramirez J, Medina-Gonzalez R, Jimenez-Cornejo M. The effect of resolution time of acute kidney injury on clinical outcomes. Indian J Nephrol. 2017;27(2):99–103.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Meraz-Muñoz A, Gomez-Ruiz I, Correa-Rotter R, Ramirez-Sandoval JC. Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: a comparative cohort study. J Crit Care. 2018;44:244–8.

    Article  PubMed  Google Scholar 

  46. Bautista E, Arcos M, Jimenez-Alvarez L, García-Sancho MC, Vázquez ME, Peña E, et al. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. Exp Mol Pathol. 2013;94(3):486–92.

    Article  CAS  PubMed  Google Scholar 

  47. Vega-Martinez D, Aguirre-Avalos G, Chavez-Iñiguez JS, Colunga-Lozano LE, Estrada-Gil FC. Precision diagnostica de prueba de estres con furosemida para prediccion de daño renal agudo severo. Rev Asoc Mex Med Crit Ter Int. 2016;30(4):230–4.

    Google Scholar 

  48. Ortega-Hernández J, Springall R, Sánchez-Muñoz F, Arana-Martinez JC, González-Pacheco H, Bojalil R. Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function. BMC Cardiovasc Disord. 2017;17(1):202.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Martínez-García JJ, León-Sicairos NM, Canizalez-Román A, García-Arellano BA. Fluid balance and acute kidney injury in septic shock. Bol Med Hosp Infant Mex. 2017;74(4):282–8.

    PubMed  Google Scholar 

  50. Cueva-Lepe AR, Risco-Cortes RE, Caballero-de AC. Estudio comparativo de hemodiafiltracion y dialisis peritoneal en niños con insuficiencia renal aguda oligurica en estado critico. Rev Asoc Mex Med Crit Ter Int. 2001;15(1):11–7.

    Google Scholar 

  51. Su-Hernández L, Abascal-Macías A, Méndez-Bueno FJ, Paniagua R, Amato D. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Perit Dial Int. 1996;16(4):362–5.

    Article  PubMed  Google Scholar 

  52. Méndez-Durán A, Ignorosa-Luna MH, Pérez-Aguilar G, Rivera-Rodríguez FJ, González-Izquierdo JJ, Dávila-Torres J. Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social. Rev Med Inst Mex Seguro Soc. 2016;54(5):588–93.

    PubMed  Google Scholar 

  53. Leaños-Miranda A, Garduño-Espinosa J, Martínez-García MC. Factors associated with peritoneal dialysis catheter failure in chronic renal insufficiency. Rev Investig Clin. 1997;49(3):189–95.

    Google Scholar 

  54. Padilla-Ochoa R, Garcia-Garcia G, Torres-Muñoz A, Lepe-Murillo L, Briseño-Renteria G, Luquin-Arellano VH, et al. Peritoneal dialysis catheter survival. A comparison between surgical and percutaneous catheter insertion techniques. Perit Dial Int. 2007;27:S7.

    Google Scholar 

  55. Murillo-Lepe L, Padilla-Ochoa R, Marquez-Magaña I, Renoirte-Lopez K, Garcia-Garcia G. PD catheter survival. A comparison between two percutaneous catheter insertion techniques. J Am Soc Nephrol. 2007;18:476A.

    Google Scholar 

  56. Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology collaborative study group. Kidney Int. 1998;54(6):2123–8.

    Article  PubMed  Google Scholar 

  57. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.

    Article  CAS  PubMed  Google Scholar 

  58. Amato D, de Jesús VM, Miranda G, Leaños B, Alcántara G, Hurtado ME, et al. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis. 2001;37(1):43–8.

    Article  CAS  PubMed  Google Scholar 

  59. Garcia-Garcia G, Tachiquín-Bautista N, Luquin-Arellano VH, Ibarra-Hernandez M, Aviles-Gomez R, Briseño-Renteria G, et al. Risk of peritonitis among disadvantaged CAPD patients in Mexico. Contrib Nephrol. 2007;154:145–52.

    PubMed  Google Scholar 

  60. Sanchez AR, Madonia C, Rascon-Pacheco RA. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Kidney Int Suppl. 2008;108:S76–80.

    Article  Google Scholar 

  61. Murguía-Miranda C, Ventura MJ, Ávila-Díaz M, Prado-Uribe MC, Mora-Villalpando C, Ilabaca B, et al. Adherence to clinical practice guidelines for anemia among Mexican chronic dialysis patients. Int J Urol Nephrol. 2016;4(4):120–7.

    Google Scholar 

  62. Paniagua R, Ventura MD, Ávila-Díaz M, Hinojosa-Heredia H, Méndez-Duran A, Cisneros A, et al. Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients. Arch Med Res. 2013;44(3):229–34.

    Article  CAS  PubMed  Google Scholar 

  63. Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, et al. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial. J Nephrol. 2019;32(4):645–59.

    Article  CAS  PubMed  Google Scholar 

  64. Rojas-Campos E, Alcántar-Medina M, Cortés-Sanabria L, Martínez-Ramírez HR, Camarena JL, Chávez S, et al. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico. Rev Investig Clin. 2007;59(3):184–91.

    Google Scholar 

  65. Aviles-Gomez R, Luquin-Arellano VH, Garcia-Garcia G, Ibarra-Hernandez M, Briseno-Renteria G. Is renal replacement therapy for all possible in developing countries? Ethn Dis. 2006;16(2):70–2.

    Google Scholar 

  66. Garcia-Garcia G, Briseño-Rentería G, Luquín-Arellan VH, Gao Z, Gill J, Tonelli M. Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol. 2007;18(6):1922–7.

    Article  PubMed  Google Scholar 

  67. Cortés-Sanabria L, Rodríguez-Arreola BE, Ortiz-Juárez VR, Soto-Molina H, Pazarín-Villaseñor L, Martínez-Ramírez HR, et al. Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis. Perit Dial Int. 2013;33(6):679–86.

    Article  PubMed  PubMed Central  Google Scholar 

  68. van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R. An international analysis of dialysis services reimbursement. Clin J Am Soc Nephrol. 2019;14(1):84–93.

    Article  PubMed  Google Scholar 

  69. Villarreal H. The artificial kidney and its applications. Rev Investig Clin. 1961;13:103–9.

    CAS  Google Scholar 

  70. Villarreal H, Flores C, Torres J, Ocando V, Colmenares P. The use of the artificial kidney in acute renal insufficiency. Arch Inst Cardiol Mex. 1962;32:569–80.

    CAS  PubMed  Google Scholar 

  71. Peña JC, Duhalt R, Navarrette R, García Zozaya JL. Periodic hemodialysis in the treatment of chronic renal insufficiency. Gac Med Mex. 1968;98(2):150–67.

    PubMed  Google Scholar 

  72. Peña JC. [The renal transplant history in the Instituto Nacional de Ciencias Médicas y de la Nutrición “Salvador Zubirán” (1966)]. Rev Investig Clin. 2005;57(2):120–123.

    Google Scholar 

  73. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7–8.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Valdez-Ortiz R, Navarro-Reynoso F, Olvera-Soto MG, Martin-Alemañy G. Mortality in patients with chronic renal disease without health insurance in Mexico: opportunities for a national renal health policy. Kidney Int Rep. 2018;3:1171–82.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Mercado-Martínez FJ, Correa-Mauricio ME. Living in hemodialysis without social insurance: the voices of renal sick people and their families. Salud Publica Mex. 2015;57(2):155–60.

    PubMed  Google Scholar 

  76. Tirado-Gómez LL, Durán-Arenas JL, Rojas-Russell ME, Venado-Estrada A, Pacheco-Domínguez RL, López-Cervantes M. An evaluation of the characteristics, processes and outcomes of hemodialysis units in Mexico. Salud Publica Mex. 2011;53 Suppl 4:491–8.

    Article  PubMed  Google Scholar 

  77. Norma Oficial Mexicana NOM-003-SSA3-2010 para la practica de hemodiálisis Mexico City: Secretaria de Salud; 2010. Available from: https://www.gob.mx/cms/uploads/attachment/file/35874/NOM-003-SSA3-2010.pdf.

  78. Paniagua R, Villasís-Keever A, MeC P-U, Ventura-García MD, Alcántara-Ortega G, Ponce de Leon SR, et al. Elevated prevalence of hepatitis B in Mexican hemodialysis patients. A multicentric survey. Arch Med Res. 2010;41(4):251–4.

    Article  PubMed  Google Scholar 

  79. González-Michaca L. Hepatitis C virus infection in patients with end stage renal disease. Rev Investig Clin. 2000;52(5):546–56.

    Google Scholar 

  80. Méndez-Sánchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol. 2004;42(9):4321–2.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Gómez-Gutiérrez C, Chávez-Tapia NC, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America. Ann Hepatol. 2015;14(6):807–14.

    Article  PubMed  Google Scholar 

  82. Mora-Bravo FG, De-La-Cruz G, Rivera S, Ramírez AM, Raimann JG, Pérez-Grovas H. Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective cohort study. BMC Nephrol. 2012;13:106.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Estaciones (unidades) de Hemodiálisis: Instituto Nacional de Geografía y Estadística (INEGI); 2016. Available from: http://www3.inegi.org.mx/rnm/index.php/catalog/291/variable/V567.

  84. Guía Tecnológica No. 15. Sistema de Hemodiálisis. Mexico City: Secretaria de Salud. Centro Nacional de Excelencia Técnica en Salud; 2004. Available from: http://www.cenetec.salud.gob.mx/descargas/biomedica/guias_tecnologicas/15gt_hemodialisis.pdf.

  85. Garcia-Garcia G, Garcia-Bejarano H, Breien-Coronado H, Perez-Cortes G, Pazarin-Villaseñor L, De la Torre-Campos L, et al. End-stage renal disease in Mexico. In: Garcia-Garcia G, Agodoa L, Norris K, editors. Chronic kidney disease in disadvantaged populations. New York: Elsevier; 2017. p. 77–82.

    Chapter  Google Scholar 

  86. Centro Nacional de Trasplantes. Reporte Anual 2017 de donación y trasplantes en Mexico. Mexico City: Secretaria de Salud; 2017. Available from: https://www.gob.mx/cms/uploads/attachment/file/289636/Presentaci_n_anual_2017.pdf.

  87. Obrador GT, Rubilar X, Agazzi E, Estefan J. The challenge of providing renal replacement therapy in developing countries: the Latin American perspective. Am J Kidney Dis. 2016;67(3):499–506.

    Article  PubMed  Google Scholar 

  88. Rosa-Diez G, Gonzalez-Bedat M, Ferreiro A, García-García G, Fernandez-Cean J, Douthat W. Burden of end-stage renal disease (ESRD) in Latin America. Clin Nephrol. 2016;86:29–33.

    Article  PubMed  Google Scholar 

  89. Centro Nacional de Trasplantes. Estado actual de receptores, donación y trasplantes en Mexico. 2do trimestre 2018. Mexico City: Secretaria de Salud; 2018. Available from: https://www.gob.mx/cms/uploads/attachment/file/343098/SegundoTrimestre2018.pdf.

  90. Reyes-Acevedo R, Obrador GT, Alberú-Gómez J, Gracida-Juárez C, André Madrigal J, Aburto-Morales S. Current state and challenges for organ donation and transplantation in Mexico. Transplantation. 2019;103(4):648–50.

    Article  PubMed  Google Scholar 

  91. Organizacion Nacional de Trasplantes. Newsletter Transplant 2018. International figures on donation and transplantation 2017. Spain: Organización Nacional de Trasplantes; 2018. Available from: http://www.ont.es/publicaciones/Documents/NewsleTTER2018finalCE.pdf.

  92. Centro Nacional de Trasplantes. Distribución y asignación de órganos y tejidos. Mexico City: Centro Nacional de Trasplantes; 2016. Available from: https://www.gob.mx/cenatra/acciones-y-programas/distribucion-y-asignacion-de-organos-y-tejidos.

  93. Medeiros-Domingo M, Romero-Navarro B, Valverde-Rosas S, Delgadillo R, Varela-Fascinetto G, Munoz-Arizpe R. Renal transplantation in children. Rev Investig Clin. 2005;57(2):230–6.

    Google Scholar 

  94. Latin American Pediatric Nephrology A, Latin American Pediatric Renal Transplant Cooperative S. Latin American registry of pediatric renal transplantation 2004–2008. Pediatr Transplant. 2010;14(6):701–8.

    Article  Google Scholar 

  95. McDonald JA, Mojarro O, Sutton PD, Ventura SJ. A binational overview of reproductive health outcomes among US Hispanic and Mexican women in the border region. Prev Chronic Dis. 2013;10:E137.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Shamah-Levy T, Cuevas-Nasu L, Gaona-Pineda EB, Gómez-Acosta LM, Morales-Rúan MDC, Hernández-Ávila M, et al. Overweight and obesity in children and adolescents, 2016 Halfway National Health and Nutrition Survey update. Salud Publica Mex. 2018;60(3):244–53.

    Article  PubMed  Google Scholar 

  97. Koshy SM, Garcia-Garcia G, Pamplona JS, Renoirte-Lopez K, Perez-Cortes G, Gutierrez MLS, et al. Screening for kidney disease in children on world kidney day in Jalisco, Mexico. Pediatr Nephrol. 2009;24(6):1219–25.

    Article  PubMed  Google Scholar 

  98. Góngora-Ortega J, Serna-Vela Francisco J, Gutiérrez-Mendoza I, Pérez-Guzmán C, Hernández-Garduño E, Ron-Torres O. Prevalence of chronic kidney disease in children in Aguascalientes, Mexico. Salud Publica Mex. 2008;50(6):436–7.

    Article  PubMed  Google Scholar 

  99. McClellan WM, Satko SG, Gladstone E, Krisher JO, Narva AS, Freedman BI. Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities. Am J Kidney Dis. 2009;53(3 Suppl 3):S100–6.

    Article  PubMed  Google Scholar 

  100. Bulum B, Ozçakar ZB, Ustüner E, Düşünceli E, Kavaz A, Duman D, et al. High frequency of kidney and urinary tract anomalies in asymptomatic first-degree relatives of patients with CAKUT. Pediatr Nephrol. 2013;28(11):2143–7.

    Article  PubMed  Google Scholar 

  101. Medeiros M, Andrade Veneros GD, Toussaint Martinez de Castro G, Ortiz Vasquez L, Hernandez Sanchez AM, Olvera N, et al. Prevalence of kidney disease in asymptomatic children with family history of renal replacement therapy. Bol Med Hosp Infant Mex. 2015;72(4):257–61.

    PubMed  Google Scholar 

  102. Medeiros M, Olvera N, Reyes R, Velasquez Jones L, Toussaint G, Obrador Vera GT. Early detection of kidney disease in children and adolescents in Mexico: a pilot study [Abstract]. J Am Soc Nephrol. 2013;24(Renal Week suppl):174A–5A.

    Google Scholar 

  103. Ortega-Romero M, Méndez-Hernández P, Cruz-Angulo MDC, Hernández-Sánchez AM, Álvarez-Elías AC, Muñoz-Arizpe R, et al. Chronic kidney disease in children aged 6–15 years and associated risk factors in Apizaco, Tlaxcala, Mexico, a pilot study. Nephron. 2019;143(4):264–73.

    Article  PubMed  Google Scholar 

  104. Medeiros-Domingo M, Romero-Navarro B, Valverde-Rosas S, Delgadillo R, Varela-Fascinetto G, Muñoz-Arizpe R. Renal transplantation in children. Rev Investig Clin. 2005;57(2):230–6.

    Google Scholar 

  105. Orta N, García C, Delucchi A, Medeiros M. Registro Latinoamericano de Trasplante Renal Pediatrico (RELATREP) 2004–2014. Arch Latin Nefr Ped. 2016;16:22–34.

    Google Scholar 

  106. Mendez-Duran A, Mendez-Bueno JF, Tapia-Yañez T, Muñoz-Montes A, Aguilar-Sanchez L. Epidemiology of chronic kidney failure in Mexico. Dial Traspl. 2010;31(1):7–11.

    Google Scholar 

  107. Fabian Velasco R, Lagunas Munoz J, Sanchez Saavedra V, Mena Brito Trejo JE, Qureshi AR, Garcia-Lopez E, et al. Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico. Pediatr Nephrol. 2008;23(3):465–71.

    Article  PubMed  Google Scholar 

  108. Robles-Vásquez N, Aguilar-Kitsu MA, Mendoza-Guevara L, Miranda-Novales MG. Complicaciones infecciosas en niños con enfermedad renal enterapia sustitutiva. Rev Med Inst Mex Seguro Soc. 2015;53(Suppl 3):S246–52.

    Google Scholar 

  109. Lopez-Gonzalez D, Garduno J, Reyes-Lopez A, Partida-Gaytan A, Medeiros M. Risk factors associated with nosocomial peritonitis in children on peritoneal dialysis. Rev Investig Clin. 2015;67(3):170–6.

    CAS  Google Scholar 

  110. Agren D. AMLO’s Mexico leads to drastic cuts to health system. Lancet. 2019;393(10188):2289–90.

    Article  PubMed  Google Scholar 

  111. Medeiros M, Castaneda-Hernandez G, Ross CJ, Carleton BC. Use of pharmacogenomics in pediatric renal transplant recipients. Front Genet. 2015;6:41.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Jacobo-Cabral CO, Garcia-Roca P, Reyes H, Lozada-Rojas L, Cruz-Antonio L, Medeiros M, et al. Limustin(R), a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients. Pediatr Transplant. 2014;18(7):706–13.

    Article  CAS  PubMed  Google Scholar 

  113. Jacobo-Cabral CO, Garcia-Roca P, Romero-Tejeda EM, Reyes H, Medeiros M, Castaneda-Hernandez G, et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. Br J Clin Pharmacol. 2015;80(4):630–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Consejo Mexicano de Nefrologia, A.C.: nefrologos con certificacion vigente: Consejo Mexicano de Nefrologia, A.C.; 2019. Available from: http://consejomexicanodenefrologia.org/nefrologos-con-certificacion-vigente/.

  115. Consejo Mexicano de Nefrologia, A.C.: Sedes de entrenamiento. Mexico City: Consejo Mexicano de Nefrologia, A.C.; 2019. Available from: http://consejomexicanodenefrologia.org/quienes-somos/.

  116. Aguilar DJ, Madero M. Other potential CKD hotspots in the world: the cases of Mexico and the United States. Semin Nephrol. 2019;39(3):300–7.

    Article  PubMed  Google Scholar 

  117. Obrador GT, Levin A. CKD hotspots: challenges and areas of opportunity. Semin Nephrol. 2019;39(3):308–14.

    Article  PubMed  Google Scholar 

  118. Lozano-Kasten F, Sierra-Diaz E, de Jesus Celis-de la Rosa A, Margarita Soto Gutiérrez M, Aarón Peregrina Lucano A, Childhood RGoSaEDi. Prevalence of albuminuria in children living in a rural agricultural and fishing subsistence community in Lake Chapala, Mexico. Int J Environ Res Public Health. 2017;14(12):1577.

    Google Scholar 

  119. Garcia-Garcia G, Gutiérrez-Padilla A, Perez-Gomez HR, Chavez-Iñiguez JS, Morraz-Mejia EF, Amador-Jimenez MJ, Romero-Muñoz AC, Gonzalez-De la Peña MDM, Klarenbach S, Tonelli M. Chronic kidney disease of unknown cause in Mexico: the case of Poncitlan, Jalisco. Clin Nephrol. 2020;93(1):42–8.

    Google Scholar 

  120. Vázquez-Rodríguez JG, Rivera-Hernández M. Perinatal complications in patients with chronic renal failure. Ginecol Obstet Mex. 2011;79(5):261–8.

    PubMed  Google Scholar 

  121. Vazquez JAG, Calva IEM, Fernandez RM, Leon VE, Cardona M, Noyola H. Pregnancy in end-stage renal disease patients and treatment with peritoneal dialysis: report of two cases. Perit Dial Int. 2007;27(3):353–8.

    Article  Google Scholar 

  122. Ibarra-Hernandez M, Orozco-Guillen OA, de la Alcantar-Vallin ML, Garrido-Roldan R, Jimenez-Alvarado MP, Castro KB, et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from Mexico. J Nephrol. 2017;30(6):773–80.

    Article  PubMed  Google Scholar 

  123. Ibarra-Hernandez M, Alcantar-Vallin ML, Soto-Cruz A, Jimenez-Alvarado PM, Villa-Villagran F, Diaz-Avila JJ, et al. Challenges in managing pregnancy in underserved women with chronic kidney disease. Am J Nephrol. 2019;49(5):386–96.

    Article  CAS  PubMed  Google Scholar 

  124. Consejo Nacional de Población. Situación de la Salud Sexual y Reproductiva. República Mexicana. Panorama demográfico y principales características de las mujeres en edad reproductiva. Mexico City: Consejo Nacional de Poblacion; 2016. Available from: https://www.gob.mx/cms/uploads/attachment/file/237216/Cuadernillo_SSR_RM.pdf.

  125. Webster P, Lightstone L, McKay DB, Josephson MA. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017;91(5):1047–56.

    Article  PubMed  Google Scholar 

  126. Agren D. AMLO’s Mexico leads to drastic cuts to health budget. Lancet. 2019;393(10118):2289–90.

    Article  PubMed  Google Scholar 

  127. Senado de la República. Gaceta de la Comisión Permanente. Iniciativa con proyecto de decreto por el que se reforma el Artículo 81 de la Ley General de Salud. Mexico City: Senado de la República. Gaceta de la Comisión Permamente; 2019. Available from: http://www.senado.gob.mx/64/gaceta_comision_permanente/documento/97421.

  128. Muñoz AE. Se crea el Instituto de Salud para el Bienestar. Mexico City: La Jornada; 2019. Available from: https://www.jornada.com.mx/ultimas/politica/2019/07/13/se-crea-el-instituto-de-salud-para-el-bienestar-8896.html.

  129. Secretaria de Salud. Proyecto Plan Nacional de Salud 2019–2024. Mexico City: Secretaria de Salud; 2019. Available from: http://www.hgm.salud.gob.mx/descargas/pdf/dirgral/Plan_Nacional_Salud_2019_2024.pdf.

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Garcia-Garcia, G. et al. (2021). Nephrology in Mexico. In: Moura-Neto, J.A., Divino-Filho, J.C., Ronco, C. (eds) Nephrology Worldwide. Springer, Cham. https://doi.org/10.1007/978-3-030-56890-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56890-0_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56889-4

  • Online ISBN: 978-3-030-56890-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics